Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 2, 1996, Pages 281-287

  Chyle, Valerian ^a   Pollack, Alan ^a   Czerniak, Bogdan ^a   Stephens, L Clifton ^b   Zagars, Gunar K ^a   Terry, Nicholas H A ^b   Meyn, Raymond E ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Bladder cancer; Downstaging; Radiotherapy

Indexed keywords

HEMOGLOBIN;

ADULT; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CYSTECTOMY; DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TISSUE SECTION; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; URINARY BLADDER NEOPLASMS;

EID: 0029952198     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(96)00089-2     Document Type: Article

References (30)

1. Altman, D. G. Practical statistics for medical research. London: Chapman and Hall; 1991:179-268.
2. Bakalkin, G.; Yakovleva, T.; Selivanova, G.; Magnusson, K. P.; Szekely, L.; Kiseleva, E.; Klein, G.; Terenius, L.; Wiman, K. G. p53 binds single-stranded DNA ends and catalizes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91:413-417; 1994.
3. Beahrs, O. H.; Myers, M. H., eds. Manual for staging of cancer, 2nd ed. American Joint Committee on Cancer. Philadelphia: J. B. Lippincott Co.; 1983:171-73.
4. Cole, C. J.; Pollack, A.; Zagars, G. K.; Dinney, C. P.; Swanson, D. A.; von Eschenbach, A. C. Local control of muscle-invasive bladder cancer: Preoperative radiotherapy and cystectomy vs. cystectomy alone. Int. J. Radiat. Oncol. Biol. Phys. 32:331-340; 1995.
5. Frazier, H. A.; Robertson, J. E.; Dodge, R. K.; Paulson, D. F. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71:3993-4001; 1993.
6. Harris, E. K.; Albert, A. Survivorship analysis for clinical studies. New York: Marcel Dekker, Inc.; 1991:5-125.
7. Hug, E. B.; Donnelly, S. M.; Shipley, W. U.; Heney, N. M.; Kaufman, D. S.; Preffer, F. I.; Schwartz, S. M.; Colvin, R. B.; Althausen, A. F. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: A possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. J. Urol. 148:47-51; 1992.
8. Jacobsen, A.-B; Pettersen, E. O.; Åmellem, Ø; Berner, A.; Ous, S.; Fosså, S. D. The prognostic significance of deoxy-ribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J. Urol. 147:34-37; 1992.
9. Kaufman, D. S.; Shipley, W. U.; Griffin, P. P.; Heney, N. M.; Althausen, A. F.; Efird, J. T. Selective bladder preservation by combination treatment of invasive bladder cancer. N. Engl. J. Med. 329:1377-1382; 1993.
10. Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257; 1972.
11. Kuerbitz, S. J.; Plunkett, B. S.; Walsh, W. V.; Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495; 1992.
12. Levine, E. L.; Davidson, S. E.; Roberts, S. A.; Chadwick, C. A.; Potten, C. S.; West, C. M. L. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 344:472; 1994.
13. Li, B.; Greenberg, N.; Stephens, L. C.; Meyn, R.; Medina, D.; Rosen, J. M. Preferential overexpression of a 172Arg→Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Diff. 5:711-721; 1994.
14. Lipponen, P. K. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer. 53:365-370; 1993.
15. Lipponen, P. K.; Aaltomaa, S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J. Pathol. 173:333-339; 1994.
16. Lowe, S. W.; Bodis, S.; McClatchey, A.; Remington, L.; Ruley, H. E.; Fisher, D. E.; Housman, D. E.; Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810; 1994.
17. Lowe, S. W.; Schmitt, E. M.; Smith, S. W.; Osborne, B. A.; Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849; 1993.
18. Meyn, R. E.; Stephens, L. C.; Ang, K. K.; Hunter, N. R.; Brock, W. A.; Milas, L.; Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64:583-591; 1993.
19. Mostofi, F. J.; Sobin, L. H.; Torlain, H. Histological typing of urinary bladder tumors. Geneva: World Health Organization; 1973.
20. Pagano, F.; Bassi, P.; Galetti, T. P.; Meneghini, A.; Milani, C.; Artibani, W.; Garbeglio, A. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J. Urol. 145:45-50; 1991.
21. Pollack, A.; Zagars, G. K.; Cole, C. J.; Dinney, C. P. N.; Swanson, D. A.; Grossman, H. B. The relationship of local control to distant metastasis in muscle-invasive bladder cancer. J. Urol. 154:2059-2064; 1995.
22. Pollack, A.; Zagars, G. K.; Dinney, C. P.; Swanson, D. A.; von Eschenbach, A. C. Preoperative radiotherapy for muscle-invasive bladder cancer: Long term follow-up and prognostic factors for 338 patients. Cancer 74:2819-2827; 1994.
23. Skinner, D. G.; Daniels, J. R.; Russell, C. A.; Lieskovsky, G.; Boyd, S. D.; Nichols, P.; Kern, W.; Sakamoto, J.; Krailo, M.; Groshen, S. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J. Urol. 145:459-467.
24. Steel, R. G. D.; Torrie, J. H. Principles and procedures of statistics: A biometrical approach. New York: McGraw-Hill; 1980.
25. Stephens, L. C.; Ang, K. K.; Schultheiss, T. E.; Milas, L.; Meyn, R. E. Apoptosis in irradiated murine tumors. Radiat. Res. 127:308-316; 1991.
26. Stephens, L. C.; Hunter, N. R.; Ang, K. K.; Milas, L.; Meyn, R. E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res. 125:75-80; 1993.
27. Stephens, L. C.; Schultheiss, T. E.; Ang, K. K.; Peters, L. J. Pathogenesis of radiation injury to the salivary glands and potential methods of protection. Cancer Bull. 41:106-114; 1989.
28. Stöckle, M.; Meyenburg, W.; Wellek, S.; Voges, G. E.; Rossmann, M.; Gertenbach, U.; Thüroff, J. W.; Huber, C.; Hohenfellner, R. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience. J. Urol. 153:47-52; 1995.
29. Wheeler, J. A.; Stephens, L. C.; Tornos, C.; Eifel, P. J.; Ang, K. K.; Milas, L.; Allen, P. K.; Meyn, Jr., R. E. Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32:1487-1493; 1995.
30. Whitmore, W. F. Total cystectomy. In: Cooper, E. H.; Williams, R. E., eds. The biology and clinical management of bladder cancer. Oxford, UK: Oxford Scientific Publications; 1975:193.